◂ Announcements

Aug 11, 2021CONTRACTHammond, Indiana, United States

Alverno Laboratories selects Ibex's AI platform for cancer diagnostics

Alverno Laboratories, a large U.S. laboratory network, selected Ibex Medical Analytics' AI-powered Galen platform to support pathologists in cancer diagnosis. The deal was announced on August 11, 2021.

Status

Completed

ProductsAI-powered cancer diagnostics platformGalen platform

CompaniesAlverno Laboratories customer Ibex Medical Analytics supplier

Sectors#Medical Devices

“Ibex transforms cancer diagnosis by harnessing Strong AI and machine learning technology at an unprecedented scale.”prnewswire.com

1 source
prnewswire.comAlverno Laboratories Selects Ibex's AI Solution for Cancer DiagnosticsIbex Medical Analytics, Alverno LaboratoriesAug 11, 2021

Summarized from public sources; check the original articles before acting on it.

Similar announcements

Nov 5, 2026CONTRACTUnited States$957.7M
Fujifilm Sonosite awarded $957.7M DLA contract for ultrasound systems
Fujifilm Sonosite Defense Logistics Agency customer pulse2.com
Mar 10, 2026CONTRACTUnited States$200K
EnSilica awarded ~$200K wireless healthcare ASIC feasibility study
EnSilica supplier stockopedia.com
Nov 6, 2026ACQUISITIONUnited States$9.90B
Danaher to acquire Masimo for $9.9 billion
Danaher acquirer Masimo target mdtvnow.com
Nov 5, 2026ACQUISITIONUnited States
Curewell Capital to acquire majority stake in ECA Medical
Curewell Capital acquirer ECA Medical target businesswire.com
Nov 5, 2026CONTRACTNETPark, Sedgefield, County Durham, United Kingdom$1.27M
Kromek Group secures £1 million follow-on order for detector components
Kromek Group businessdurham.co.uk
Nov 5, 2026PARTNERSHIPUnited States$455.0M
Boston Scientific and Blackstone Life Sciences agree to $455M co-funding deal for heart pump
Boston Scientific partner Blackstone Life Sciences partner medtechdive.com

Loading…